PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat
Ғылым және технология
UCLA oncologist Gottfried Konecny, MD, gives an overview of the PARP inhibitors olaparib, niraparib, and rucaparib, which have been approved for the treatment of ovarian cancers and how to proactively plan for and manage treatment-related toxicities. #UCLAMDChat
Пікірлер: 15
Absolutely fantastic. Best PARPi video I've ever seen - this helped me SO MUCH. THANK YOU!
This was the clear explanation I was looking for. More doctors like you should make videos like this. I appreciate the time you took to explain this new therapy!
Thankyou... found this gem after almost three hours of hearing jargons on other channels:-)
I am on Lynparzza and this helped me understand a lot more than I did.
I love science. Great presentation, thanks Gottfried
Excellent! You have answered so many of my questions! Thank You 🙏🏼
Character In the video It's great, I like it a lot $$
Updated video plz on this topic
Nice info
Plz sir reply me plzzzz... Can I take Rucaparib with in 6 months of last chemo ?????? Plz sir help me😭
My mother had ovarian cancer .
@viorelscrob6391
3 жыл бұрын
@Smudge Smudge no i didn't take any test.
@viorelscrob6391
3 жыл бұрын
@Smudge Smudge i should do?
Is that from great America and the spit in the eye